Patents by Inventor Stuart Richard Crosby

Stuart Richard Crosby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11161869
    Abstract: The present invention relates to chemical linkers and protecting groups, compounds and compositions containing the chemical linkers or protecting groups, and intermediates and processes that can be used to prepare them. The chemical linkers and protecting groups are based on pyrrolidine and piperidine activating groups, which undergo intramolecular cyclisation upon heating with release of carbon dioxide, thereby releasing the organic compound from a substrate. In particular, those chemical linkers and protecting groups are useful in the solid phase synthesis of oligonucleotides according to the following representative schemes.
    Type: Grant
    Filed: April 12, 2018
    Date of Patent: November 2, 2021
    Assignee: Evonetix Ltd.
    Inventors: Stuart Richard Crosby, Mathew Jennison, Joseph Brennan
  • Patent number: 9433622
    Abstract: Compounds of the general formula (I) and salts thereof are useful in the treatment of diseases associated with aberrant activity of the protein kinases IKK? and/or TBK-1 in which one of V and W is N, and the other of V and W is C—H; and R1, R2, R3 and R4 are as defined in the specification. The invention also provides uses of the compounds and compositions containing them.
    Type: Grant
    Filed: February 21, 2014
    Date of Patent: September 6, 2016
    Assignee: Case Western Reserve University
    Inventors: Gary Karl Newton, Mark Richard Stewart, Trevor Robert Perrior, Stuart Richard Crosby, Anna Hopkins, Gabriel Negoita-Giras, Kerry Jenkins
  • Publication number: 20160000784
    Abstract: Compounds of the general formula (I) and salts thereof are useful in the treatment of diseases associated with aberrant activity of the protein kinases IKK? and/or TBK-1 in which one of V and W is N, and the other of V and W is C—H; and R1, R2, R3 and R4 are as defined in the specification. The invention also provides uses of the compounds and compositions containing them.
    Type: Application
    Filed: February 21, 2014
    Publication date: January 7, 2016
    Applicant: DOMAINEX LIMITED
    Inventors: Gary Karl Newton, Mark Richard Stewart, Trevor Robert Perrior, Stuart Richard Crosby, Anna Hopkins, Gabriel Nefoita-Giras, Kerry Jenkins
  • Publication number: 20110124626
    Abstract: A compound having the formula (1) wherein: R1 is a group selected from C3-8 cycloalkyl, C1-6 alkyl, C1-6 alkylene-C3-8 cycloalkyl, each of which groups may optionally be substituted with C1-6 alkyl, halogen, haloC1-6 alkyl or OR15, or R1 is heterocyclyl, optionally substituted with C1-6 alkyl, haloC1-6 alkyl or OR15; n is 0, 1, 2, 3 or 4, the alkylene group —(CH2)m— formed thereby being optionally substituted with a group selected from C1-4 alkyl, C3-8 cycloalkyl and arylsulfonyl; A is a group selected from —N(R2)CO—, —CON(R2)-, —OC(O)—, —C(O)O—, —CO—, —C(R2)(OR3)-, —C(?N—O—R3)-, —C(?CR2R3)-, —C3-8 cycloalkylene-, —C(R2)(haloC1-6alkyl)-, C1-4 alkylene and —C(OR3)(haloC1-6alkyl)-; R2 and R3 are each independently selected from H, C1-6 alkyl, and C3-8 cycloalkyl, or, when A is —N(R2)CO— and X is absent, R2 may form, together with the adjacent nitrogen atom and Z, an N-containing heterocyclyl group, which may optionally be substituted; X is absent or is C14 alkylene or C24 alkenylene, each of which may optionall
    Type: Application
    Filed: July 17, 2009
    Publication date: May 26, 2011
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Parminder Kaur Pooni, Kevin John Merchant, Catrina Morvern Kerr, Stuart Richard Crosby, Tomohiro Okawa, Mitsuru Sasaki, Mika Gotou, Graham Andrew Showell, Martin Richard Teall